Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0907592 on January 18, 2008

Published online before print January 18, 2008
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.0907592v1
83/4/936    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woller, G.
Right arrow Articles by Petersen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woller, G.
Right arrow Articles by Petersen, F.
(Journal of Leukocyte Biology. 2008;83:936-945.)
© 2008 by Society for Leukocyte Biology

Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals

Geske Woller*, Ernst Brandt*, Jessica Mittelstädt*, Christian Rybakowski{dagger} and Frank Petersen*,1

* Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany; and
{dagger} District Hospital Segeberger Kliniken, Bad Segeberg, Germany

1 Correspondence: Department of Immunology and Cell Biology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany. E-mail: fpetersen{at}fz-borstel.de


arrow
ABSTRACT
 
The generation of reactive oxygen species (ROS) represents a pivotal element of phagocyte defense against microbial invaders. However, oxidative stress also participates in pathophysiological processes of vascular damage leading to cell death of endothelial cells (EC). Currently, ROS-producing cells involved in this process as well as the corresponding extracellular signals required for their activation are ill-defined. In this study, we investigate the impact of the platelet-derived CXC chemokine platelet factor 4 (PF4/CXCL4) on the interaction of human monocytes and EC. We can show for the first time that PF4-activated monocytes become cytotoxic for EC but not epithelial cells. Cytotoxicity was time- and dose-dependent, and earliest effects were seen after 15 h of culture and at a concentration from 0.125 µM PF4 up. By performing transwell experiments and by using specific inhibitory antibodies, we could show that direct cell contact between effector and target cells, mediated by β2integrins as well as their corresponding ligand ICAM-1, is essential for the cytotoxic effect. Investigations of the cellular mechanisms of cytotoxicity revealed that in the presence of EC, PF4-activated monocytes are capable of releasing high amounts of ROS for more than 2 h following stimulation. This causes programmed cell death in EC, as inhibitors of the NADPH oxidase (diphenyleneiodonium and apocynin) effectively blocked PF4-induced monocyte oxidative burst and protected EC from undergoing apoptosis. Taken together, our data suggest a role for platelet-derived PF4 in oxidative stress-mediated vascular disorders, as observed during atherosclerosis or ischemia/reperfusion injury.

Key Words: macrophages • chemokines • cytotoxicity


arrow
INTRODUCTION
 
Platelets and many of their products are well known for their role in the induction of hemostatic events. However, defining the role of platelets in the control of immunological responses is a matter of intensive research. Activated platelets release a variety of prestored mediators, including three chemokines: connective tissue-activating peptide III (CTAP-III)/neutrophil-activating peptide 2 (NAP-2; CXCL7), RANTES (CCL5), and platelet factor 4 (PF4; CXCL4; reviewed in refs. [1 , 2 ]). Although PF4 and CTAP-III are virtually absent in plasma, they are found at micromolar concentrations in serum [3 ]. NAP-2, which represents an N-terminally truncated derivative of CTAP-III, is a chemoattractant for neutrophils and induces the release of granule contents, such as elastase, as well as a rise in cytosolic-free calcium in these cells [4 ]. RANTES activates monocytes, T cells, and dendritic cells (reviewed in refs. [5 6 7 ]). PF4 has a number of pleiotropic functions, which can be induced in a broad spectrum of different cell types. Although structurally a member of the chemokine family, PF4 does not mediate typical chemokine functions such as the induction of chemotaxis or intracellular Ca2+ fluxes [8 9 10 ]. Nevertheless, PF4 was shown to induce the release of histamine by basophils [11 ], adherence of eosinophils [12 ], as well as IL-8 release by NK cells [13 ]. For neutrophils, we have shown that PF4 induces the exocytosis of secondary granule contents and induces a strong adherence to endothelial cells (EC) [14 , 15 ].

Besides inducing short-term responses, PF4 contributes to long-term regulatory processes of cell activation and differentiation, such as the support of the survival of hematopoietic stem cells and progenitor cells [16 ]. Furthermore, PF4 acts as a potent inhibitor of T cell activation [17 , 18 ] and EC proliferation [19 ]. Although the effect on the former cells is mediated indirectly by interference with the autocrine IL-2 loop, the regulation of EC appears to be more complicated. The latter involves competition of PF4 with growth factors for binding to coreceptors, direct interaction with growth factors, as well as direct binding to CXCR3B, a recently described splice variant of CXCR3 [20 21 22 23 ]. Furthermore, it has been shown that PF4 reversibly abolishes the entry of these cells into S-phase and thereby inhibits DNA synthesis [24 ].

Although in most cell types, PF4 exclusively mediates long-lasting or short-term biological responses, a complex spectrum of different consecutive functions is observed in monocytes. During an initial phase of up to 60 min, PF4 induces the generation of oxygen radicals and phagocytosis in these cells [25 ]. This period is followed by an intermediary phase of 2–8 h, which is characterized by functions such as tight adhesion of monocytes and the release of TNF-{alpha}. Thereafter, PF4 initiates a cellular program, which prevents monocytes from undergoing spontaneous apoptosis and induces differentiation of these cells into a specific subtype of macrophage. Different from GM-CSF- or M-CSF-derived macrophages, PF4-treated cells lack surface expression of HLA-DR but show an up-regulation of the costimulatory molecule B7-2 [26 ]. Moreover, the latter cell type displays enhanced innate immune functions such as phagocytosis as well as the generation of reactive oxygen species (ROS) [27 ].

The interaction of monocytes with EC of the vessel wall is a crucial process in tissue homeostasis as well as under pathological conditions of inflammation or tissue injury. Depending on the respective situation, monocytes may migrate through this barrier, remove damaged cells, and initiate wound healing and angiogenesis. On the other hand, activated monocytes are involved in vascular diseases such as reperfusion injury and atherosclerosis (reviewed in ref. [28 ]). In the present study, we have investigated the molecular basis as well as the functional consequences of the interaction of EC with PF4-activated monocytes. Here, we can show that human blood monocytes triggered with PF4 have a considerable cytotoxic effect on resting EC. This cytotoxic effect is mediated by the formation of oxygen radicals leading to the induction of programmed cell death of EC.


arrow
MATERIALS AND METHODS
 
Materials
Pyrogen-free, distilled water was obtained from Braun (Heidelberg, Germany), and endothelial basal medium bulletkit (EBM) was from Cambrex Bio Science (Verviers, Belgium). Medium 199 (M199), DMEM, penicillin/streptomycin (PEST), as well as 0.5% trypsin/0.2% EDTA solution were purchased from Biochrom (Berlin, Germany). Glutamine (Glu), BSA, low endotoxin, and FCS were obtained from PAA Laboratories (Linz, Austria). Gelatine and cell dissociation solution were from Sigma (Munich, Germany), and collagenase and luminol (5-amino-2,3-dihydro-1,4-phthalazindione) were from Roche (Mannheim, Germany). UptiBlue reagent was purchased from Interchim (Monfluçon Cedex, France), and Annexin-V kit was obtained from Bender MedSystems (Vienna, Austria). The inhibitors diphenyleneiodonium (DPI) and apocynin were from Calbiochem (Bad Soden, Germany). Human natural PF4 was purified to homogeneity from release supernatants of thrombin-stimulated platelets in a three-step procedure. First, the major contaminant β-thromboglobulin (β–TG) antigen was removed by immunoaffinity chromatography, as described previously [29 ]. The flow-through was collected, supplemented with Triton X-100 to yield a final concentration of 0.1%, and subjected to immunoaffinity chromatography on immobilized anti-PF4 mAb (clone PF63.1) as described [30 ]. Material eluting in a single peak at pH 2.5 was finally purified to homogeneity by reversed-phase HPLC, as reported earlier [31 ]. The preparations contained less than 0.125 pg LPS/µg PF4 (i.e., below 4 pg/ml at 4 µM PF4), as determined by the Limulus amoebocyte lysate assay, ruling out possible side-effects caused by contaminating LPS. Furthermore, PF4, at concentrations of 100 µg/ml, was incapable of activating TLR4-transfected human embryo kidney (HEK)293 cells (kindly performed by Dr. H. Heine, Division of Innate Immunity, Research Center Borstel, Germany). PF4 was lyophilized, stored at –80°C, and reconstituted to stock solutions of 2 mg/ml in 0.1% trifluoracetic acid prior to use. Recombinant human GM-CSF was from Immunotools (Friesoythe, Germany). The mAb directed against CD18 (clone MHM23) and CD54 (clone 6.5B5) were purchased from Dako (Hamburg, Germany), mAb directed against CD102 (clone B-T1) from Immunotech (Marseille, France), and allophycocyanin (APC)-labeled mAb directed against CD14 (clone TÜK4) from Miltenyi Biotech (Bergisch Gladbach, Germany). An antibody directed against β-TG (clone C-24), which was generated in our laboratory [32 ], was used as an isotype control (IgG1/{kappa}).

Cell preparation and culture
Human EC were isolated from umbilical cord veins by collagenase treatment and cultured in dishes precoated with 0.04% gelatine, according to Jaffe et al. [33 ], with minor modifications described by Schönbeck et al. [34 ]. Briefly, the cells were maintained in the EC culture medium EBM in 25 cm2 cell culture flasks. For experiments, cells were subcultured after trypsinization in 96-well microtiter plates in 200 µl at a density of 5000 cells/cm2. Cells were cultured until confluence and used throughout passages 1 and 2.

Monocytes were obtained from peripheral blood of healthy volunteer donors by Ficoll-Paque gradient centrifugation and subsequent counterflow centrifugation as described earlier [35 ]. The purity of the monocytes in all experiments was more than 95%. Approval for these studies was obtained from the Institutional Review Board at the University of Lübeck (Germany), and informed consent was provided according to the declaration of Helsinki.

The human lung epithelial cell line A549 (American Type Culture Collection (Manassas, VA, USA) was cultured in DMEM supplemented with 10% FCS, 1% L-Glu, and 1% PEST.

For coculture with EC, 100 µl aliquots of monocytes (1.25x105/ml) were added to microtiter plates onto confluent EC layers in coculture medium (M199/0.1% BSA/1% L-Glu/1% PEST). In some experiments, concentrations of monocytes varied from 0.625 x 105/ml up to 20 x 105/ml. Unless otherwise indicated, cocultures were performed in the presence or absence of PF4 (4 µM) or GM-CSF (500 U/ml) for 18 h. Alternatively, cocultures were performed with cells of the epithelial cell line A549 instead of EC. In some experiments, the cell cultures were treated additionally with DPI (4 µM), apocynin (1 mM), or antibodies directed against CD18, CD54, or CD102 at concentrations of 10 µg/ml for each antibody.

To prevent direct cell contact between monocytes and EC, some cocultures were performed in transwell units (pore size 0.2 µM, Nunc, Wiesbaden, Germany). Therefore, EC were grown on the bottom of the plates, and monocytes were placed in the transwell units.

In a separate set of experiments, EC were cultured with monocyte-conditioned medium. Therefore, increasing concentrations of monocytes (0.625x105/ml–2.5x105/ml) were stimulated for 18 h with 4 µM PF4 or remained unstimulated. Cell-free supernatants were collected and subsequently added to EC.

Cytotoxicity assay
The cytotoxic effect of monocytes against EC and epithelial cell line A549 was determined by using the UptiBlue reagent. The indicator is added to the cells in its oxidized form and subsequently becomes reduced by mitochondrial enzyme activity of the viable cells. The chemical reduction exhibits a change in color that can be quantified colorimetrically [36 ]. According to the recommendations of the manufacturer, 10 µl of the reagent was added to each well containing monocytes and EC and was incubated for an additional 3 h. Thereafter, absorbance was recorded by an automatic photometer at wavelengths of 570 and 600 nm, and the relative cytotoxicity was calculated according to the following formula: Percent cytotoxicity = [1–((At–Am)/Ab)] x 100; where is A = difference between the absorbance measured at 570 and 600 nm; t = A in the coculture of monocytes and EC/A549; m = A in the culture of monocytes alone; and b = A in the culture of EC/A549. Ab was determined in parallel in cultures that received medium alone or a corresponding amount of PF4. No differences in cell viability were observed between both cultures. Routinely, cocultures were additionally analyzed for cell integrity by phase-contrast microscopy, and photographs of representative sections were taken.

Oxygen radical formation
Generation of ROS by monocytes was determined by measurement of chemiluminescence in the presence of luminol as described elsewhere [37 ]. Briefly, 200 µl aliquots of monocytes (1x106/ml) were distributed into an intransparent, 96-well microtiter plate (Nunc) on the plastic surface or on confluent EC, and chemiluminescence was recorded for 2 h. Results were expressed as relative light units (RLU). Some experiments were performed in the presence of the NADPH oxidase inhibitors DPI (0.5–8 µM) and apocynin (0.25–4 mM), which were added 15 min before PF4 treatment.

Evaluation of cell viability and detection of apoptosis
Determination of apoptotic cells was done by double-staining with Annexin-V-FITC and propidium iodide (PI) using an Annexin-V kit. Briefly, after the detachment of EC and monocytes by exposure to cell dissociation solution, cells were incubated with Annexin-V-FITC in binding buffer (provided by the manufacturer) for 20 min on ice, washed, and resuspended in the same buffer as described by the manufacturer. Monocytes were identified by staining with APC-labeled anti-CD14 and excluded from further analysis. PI (1 µg/ml finally) was added immediately before flow cytometrical analysis, performed with a FACSCalibur (Becton Dickinson, Heidelberg, Germany).

Statistics
All experiments were performed at least three times with cells from different individuals, and the data are expressed, unless indicated otherwise, as mean of the replicates ± SD. Statistical significance was analyzed by Wilcoxon-matched pairs test or by Kruskal-Wallis test.


arrow
RESULTS
 
PF4-activated monocytes are cytotoxic for EC
To investigate the impact of PF4 on the interaction of monocytes and EC, freshly isolated monocytes were cultured in the presence or absence of PF4 on confluent layers of EC. As PF4 at a concentration of 4 µM was shown to be optimal for the induction of several monocytic functions [38 , 39 ], this concentration was chosen for a first approach. As GM-CSF and PF4 induce an overlapping spectrum of biological functions in monocytes [40 , 41 ], both cytokines were used in parallel. During the 18 h of incubation, cocultures were routinely monitored every 4–8 h by phase-contrast microscopy. Up to 4 h of culture, no differences could be observed between each sample (data not shown). However, by 18 h, dramatic changes in PF4-containing cultures became apparent. Whereas EC layers exposed to unstimulated or to GM-CSF-stimulated monocytes remained intact (Fig. 1A and 1B ) and showed no difference to EC cultured in the absence of monocytes (data not shown), EC layers cultured in the presence of PF4-stimulated monocytes appeared to be completely destroyed (Fig. 1C) . PF4 (Fig. 1D) or GM-CSF (data not shown) alone in the absence of monocytes was without effect on EC.


Figure 1
View larger version (148K):
[in this window]
[in a new window]

 
Figure 1. Effect of monocytes on the integrity of EC. Monocytes (5x105/well) were cultured in the absence [unstimulated (unst.); A] or in the presence of 500 µ/ml GM-CSF (B) or 4 µM PF4 (C) on confluent layers of EC for 18 h in 24-well plates. In control cultures, EC received 4 µM PF4 in the absence of monocytes [without monocytes (w/o Monoc.; D]. Photographs of representative sections were taken by phase-contrast microscopy (20-fold magnification). The data from one representative experiment out of five are given.

In the next step, kinetic studies about PF4-mediated cytotoxicity were performed. To quantify the cytotoxic effect on EC, the number of residual living cells was determined by using the redox indicator UptiBlue. To rule out a potential direct effect of PF4 on EC, reference cultures of these cells without monocytes were performed in all of the following experiments in the absence or presence of PF4. No differences in cytotoxicity were seen between these cultures. In a first run, the effect of increasing concentrations of PF4 on a constant number of monocytes (0.125x105/well) at 18 h of coculture with EC was analyzed. Under these conditions, a first cytotoxic effect was seen at 125 nM PF4. Increasing PF4 concentrations resulted in a dose-dependent enhancement of cytotoxicity rates, reaching a plateau at 4 µM PF4 (Fig. 2A ). In the next step, time dependency of PF4-induced cytotoxicity was determined at constant concentrations of monocytes and PF4 (0.125x105/well and 4 µM, respectively). As depicted in Figure 2B , a first difference between PF4-stimulated cultures and untreated control cells was seen after 12 h of culture and became statistically significant after 15 h of incubation, and GM-CSF was without significant effect. When the coculture was extended to more than 18 h, an increase of cytotoxicity in all three samples, i.e., in PF4-treated and GM-CSF-treated as well as unstimulated control cells, was observed. Finally, cytotoxic effect on EC was monitored at varying concentrations of monocytes. Irrespective of whether a stimulus was present, monocytes were able to kill EC in a dose-dependent manner (Fig. 2C) . Furthermore, PF4-activated monocytes at all cell densities tested displayed a higher capacity to destroy EC than unstimulated cells. However, differences between PF4-stimulated und untreated cultures decreased with increasing numbers of monocytes. Although at monocyte concentrations of 0.625 and 1.25 x 104 cells/well in PF4-treated cultures, an approximate sixfold higher cytotoxicity as compared with unstimulated controls was observed, this difference was reduced to 1.6-fold at 20 x 104 monocytes/well. According to our findings, PF4-induced cytotoxicity of monocytes against EC was optimal after 18 h of culture in the presence of 4 µM PF4 at cell densities of 0.625 x 104–1.25 x 104 monocytes/well. Consequently, these conditions were chosen for all further experiments. After having optimized the experimental conditions, the question arose whether PF4-induced monocyte cytotoxicity is specific for EC as a target cell or extends to other adherent cell types. Consequently, we also tested the capacity of PF4-stimulated monocytes to lyse cells of the lung epithelial cell line A549. In an approach comparable with that shown in Figure 2C , increasing numbers of unstimulated as well as PF4-treated monocytes were exposed to confluent layers of the target cells. Although monocytes were able to kill these cells, PF4 activation did not increase cytotoxicity (Fig. 2D) . Similar findings were obtained using human fibroblasts as target cells (data not shown). These findings suggest that PF4-stimulated monocytes were not generally cytotoxic for adherent cells and showed a selective cytotoxic effect on EC.


Figure 2
View larger version (30K):
[in this window]
[in a new window]

 
Figure 2. Dependency of PF4-induced monocyte cytotoxicity on stimulus concentration, effector cell density, culture time, and target cell type. (A) Monocytes (0.125x105 cells/well) were exposed for 18 h to confluent layers of EC in 96-well plates in the absence or presence of increasing concentrations of PF4. (B) Monocytes (0.125x105/well) were left unstimulated (open bars) or stimulated with 4 µM PF4 (black bars) or 500 µ/ml GM-CSF (gray bars) and cultured for different time periods on EC layers. Alternatively, increasing numbers of monocytes were stimulated with 4 µM PF4 (solid bars) or left untreated (open bars), followed by 18 h exposure to EC (C) or to A549 cells (D). Cytotoxicity was calculated on the basis of residual living cells determined by using the UptiBlue system, where EC, cultured with or without PF4 in the absence of monocytes, was set as 100% living cells. Data represent mean ± SD of four (B) and three (A, C, and D) independent experiments. Statistically significant differences between cytotoxicity of PF4-treated or untreated approaches are indicated (*, P≤0.01).

Cytotoxicity requires cell contact of monocytes and EC
Cytokines and other soluble mediators produced by monocytes have profound effects on EC function [42 ] and mediate killing of certain tumor targets. To clarify whether monocyte-derived soluble factors induced by PF4 could be responsible for the killing of EC, the latter cells were exposed to cell-free supernatants of monocytes stimulated for 18 h with the chemokine or GM-CSF. Although in cocultures of monocytes with EC, PF4 induced a marked cytotoxic effect, conditioned supernatants had only a slight effect on EC (Fig. 3A ). Furthermore, neither GM-CSF-activated monocytes nor conditioned supernatants of these cells were able to kill EC. To further investigate whether the monocyte cytotoxicity requires direct cell contact or possibly involves unstable mediators, which do not accumulate in supernatants, monocytes and EC were separated by a membrane (0.2 µM pore size) in a transwell system during coculture. Under these conditions, PF4-activated monocytes were not able to induce a cytotoxic effect that exceeded the unspecific cytotoxicity of unstimulated cells (Fig. 3B) . These data provide initial evidence that a direct cell contact is essential for PF4-mediated cytotoxicity.


Figure 3
View larger version (27K):
[in this window]
[in a new window]

 
Figure 3. Role of cell contact and adhesion molecules in PF4-mediated cytotoxicity. Monocytes (0.125x105/well) were stimulated with 4 µM PF4 (black bars), 500 µ/ml GM-CSF (gray bars), or left untreated (open bars). Subsequently, EC were cocultured in the presence of monocytes or exposed to cell-free supernatants derived from stimulated or unstimulated monocytes cultured for 18 h (A). Alternatively, stimulated or unstimulated monocytes were cocultured with EC under conditions that allowed a direct cell contact or where cell contact was prevented by a transwell membrane (0.2 µM pore size; B). Furthermore, PF4-treated as well as untreated monocytes were cocultured on EC layers in the presence of antibodies directed against the common chain of β2 integrin (10 µg/ml; C) or ICAM-1 as well as ICAM-2 (10 µg/ml, respectively; D) or corresponding isotype controls. After 18 h, cytotoxicity was measured by UptiBlue reagent. Data represent mean ± SD of three (B and D) or five (A and C) independent experiments.

In most cases, direct cell contacts involve an interaction of adhesion molecules. We have shown previously that in the PF4-mediated adherence of neutrophils to EC, the interaction of β2 integrins with ICAM-1 and ICAM-2 plays an essential role [43 , 44 ]. To investigate the potential relevance of integrins on the cytotoxic effects of monocytes, cocultures were performed in the presence of antibodies directed against the common β-chain of the β2 integrins (CD18) or against the corresponding ligands ICAM-1 and ICAM-2. As compared with controls, which received antibodies of an appropriate isotype, the presence of antibodies against CD18 or ICAM-1 in cocultures drastically reduced PF4-mediated cytotoxic effects on EC (Fig. 3C and 3D) . Treatment of cultures with anti-ICAM-2 was without effect in this context, and a combination of both ICAM antibodies did not alter the effect seen with anti-ICAM-1 alone (data not shown). In a parallel set of experiments, we analyzed EC for surface expression of adhesion molecules (ICAM-1, ICAM-2, and E-selectin). Although as expected, E-selectin was absent on resting EC, we found a clear expression of both ICAM molecules (data not shown). Therefore, the lack of an effect of anti-ICAM-2 antibodies on monocytes–cytotoxicity cannot be explained by a simple absence of the molecule on the EC surface. Furthermore, treatment of EC with PF4 for up to 18 h did not change the expression of the adhesion molecules tested (not shown).

Taken together, we conclude that PF4-mediated cytotoxicity of monocytes against EC depends on a direct cell contact, which is mediated by ICAM-1 on EC and β2 integrins on monocytes.

Monocytes kill EC by the formation of radical oxygen species
Next, we investigated the mechanisms by which monocytes mediate their cytotoxic effects on EC. In preliminary experiments, we could show that 5% FCS was able to completely abrogate the cytotoxic effect of the chemokine (data not shown). As serum is known to contain several protease inhibitors, we first investigated the role of proteases in this regard. However, neither inhibitors of serine proteases or cysteine proteases (aprotinin and leupeptin, 0.25–1 µg/ml, respectively) nor a general inhibitor of endoproteases ({alpha}2-macroglobulin, 1 mg/ml) showed any effect on the PF4-mediated cytotoxicity (data not shown). As this set of inhibitors covers all prominent monocyte proteases, we exclude a relevant role for these enzymes. As it is known that serum, besides inhibitors of proteases, also contains scavengers for ROS, we examined next whether these short-lived products of monocytes are involved in the cytotoxic process. In a first approach, we tested whether PF4-stimulated monocytes, when attached to EC, are able to produce ROS. As a control, monocytes were allowed to settle on a plastic surface prior to stimulation. Under both conditions, approximately within 2–5 min after contact with PF4, monocytes started to release ROS, which reached a maximum after 20 min of stimulation. However, although ROS production in monocytes attached to plastic surfaces returned to background levels after 80 min, in the presence of EC, release of oxygen metabolites remained nearly unchanged at high levels for over 2 h of data recording (Fig. 4A ). This indicates that EC cocultured with PF4-stimulated monocytes may be exposed to oxidative stress for rather long time periods. Statistical analysis of the integrated data based on four experiments revealed that during the first 60 min, no significant difference between cells attached to plastic and EC occurred (P=0.1157). However, ROS production of monocytes adherent to EC was significantly higher than that by cells layered on plastic when the calculation was based on an interval of 120 min of stimulation (P<0.048). Interestingly, under the same conditions, no difference between monocytes attached to plastic or to EC was seen when fMLP (1 µM) was used for monocyte activation (data not shown), and GM-CSF (250–1000 U/ml) was incapable of inducing any ROS production (not shown). Most strikingly, comparable with their effect on PF4-induced cytotoxicity, antibodies directed against ICAM-1 or CD18 also inhibited PF4-induced ROS production. Although in the presence of anti-ICAM-1, burst rates were reduced by more than 60%, formation of ROS was completely abrogated in samples that received antibodies to CD18 (Fig. 4A) . Corresponding antibodies of the same isotype were without effect on PF4-induced release of oxygen radicals (data not shown). To prove that ROS are responsible for the cytotoxic effect of monocytes on EC, two inhibitors of NADPH oxidase, apocynin and DPI, were used. Both inhibitors were able to block oxygen radical formation induced by PF4 in a dose-dependent manner, with complete inhibition observed at 1 mM apocynin or 8 µM DPI (Fig. 4B) . Consequently, both inhibitors were used in cocultures of monocytes and EC in the presence of PF4. However, as these substances interfere with the detection of viable cells by redox indicators such as UptiBlue and formazan [45 ], analyses were performed by phase-contrast microscopy. In the absence of inhibitors, PF4-activated monocytes completely destroyed the EC layer (Fig. 4C , left panel). Conversely, treatment of cultures with apocynin or DPI (Fig. 4C , middle and right panels, respectively) drastically inhibited the PF4 effect. Approximately 80–90% of the EC layer remained intact compared with a parallel culture without PF4. Both inhibitors were without effect on EC control cultures, receiving unstimulated monocytes or PF4 in the absence of these cells (data not shown). These data provide direct evidence that ROS released from PF4-activated monocytes are responsible for the cytotoxic effect on EC.


Figure 4
View larger version (69K):
[in this window]
[in a new window]

 
Figure 4. The role of monocyte-derived ROS in PF4-mediated cytotoxicity. (A) Monocytes attached to a plastic surface or to an EC layer were stimulated with 4 µM PF4 (solid lines), and formation of oxygen radicals was visualized by chemiluminescence. Additionally, PF4-stimulated monocytes adherent to EC received antibodies (10 µg/ml) directed against ICAM-1 (dotted line) or CD18 (dashed line). (B) Monocytes were left untreated or pretreated with increasing concentrations of apocynin (gray bars) or DPI (black bars), followed by stimulation with 4 µM PF4. The formation of oxygen radicals was determined by chemiluminescence, and the data were recorded for 60 min. The data were integrated and shown as mean ± SD of three independent experiments. (C) Monocytes (3x105/well) were stimulated with 4 µM PF4 and cultured in the absence or presence of 1 mM apocynin or 8 µM DPI on confluent layers of EC. After 12 h of incubation, photographs of representative sections were taken by phase-contrast microscopy (20-fold original magnification). The data from one representative experiment out of three are given.

Oxygen radicals released from PF4-activated monocytes induce apoptosis of EC
In a final approach, we tried to determine the mode of action by which oxygen radicals provoke the cell death of EC. Most recently, Madesh and colleagues [46 ] could demonstrate that chemically induced oxidative stress leads to apoptosis of rat EC. Thus, we incubated PF4-stimulated monocytes for 12 h with EC and determined the numbers of apoptotic EC by Annexin-V staining. As illustrated in Figure 5 , the proportion of apoptotic EC increased up to 21% in PF4-containing cocultures, and only 9% of the EC underwent programmed cell death in the absence of the chemokine. Furthermore, the numbers of necrotic/late apoptotic EC (Annexin-V/PI double-positive cells) were higher in PF4-treated than in untreated cells (20% and 14% apoptotic cells, respectively). Finally, we investigated the effect of NADPH oxidase inhibitors on the induction of apoptosis in EC by PF4-activated monocytes. Comparable with the results shown in Figure 5A , addition of PF4 to monocyte EC cocultures resulted in an increase in apoptotic cell numbers from 8% up to 18% (Fig. 5B) . Nevertheless, in the presence of apocynin or DPI, no such increase was observed (9% and 11% apoptotic cells, respectively). Apoptosis rates of EC alone or in the presence of unstimulated monocytes were not affected by the inhibitors. Taken together, our results show that oxygen radicals released from PF4-treated monocytes are responsible for the induction of apoptosis in EC.


Figure 5
View larger version (34K):
[in this window]
[in a new window]

 
Figure 5. PF4-stimulated monocytes induce apoptosis in EC. Monocytes (3x105/well) were added to EC layers in 24-well plates in the absence or presence of 4 µM PF4. After 12 h of incubation, EC were nonenzymatically detached, and numbers of apoptotic cells were determined by Annexin-V/PI double-staining by flow cytometry. Monocytes were identified in the same samples by using a CD14-APC antibody and excluded from further analysis. Data from one representative experiment out of nine are shown (A). In a parallel set of experiments, untreated (gray bars) or PF4-stimulated (black bars) monocytes (Mo) were cultured in the presence of 1 mM apocynin or 8 µM DPI on confluent EC, and EC cultured without monocytes (open bars) served as a control. Analysis of apoptotic EC was performed as described above. Data represent mean ± SD derived from nine independent experiments (B). Statistically significant differences between PF4-treated cocultures alone and those that received additional inhibitors are indicated (*, P<0.021).


arrow
DISCUSSION
 
In the present study, we report on a novel functional role of the platelet-derived chemokine PF4/CXCL4 in the interaction of monocytes with EC. According to our findings, PF4 induces in the former cells the capacity to kill EC but not epithelial cells. This cytotoxic effect is mediated by a long-lasting release of oxygen radicals from the activated monocytes, leading to a programmed cell death of the endothelium.

The generation of ROS, which occurs at low levels in nearly all cell types, is one of the fundamental defense mechanisms of phagocytic leukocytes against microbial invaders. However, uncontrolled production of ROS is involved in severe tissue damage, as observed in emphysema, reperfusion injury, or rheumatoid arthritis [47 ]. The mechanism underlying ROS-mediated damage of cells and tissues is poorly understood. Recent data provide evidence that oxidative stress may act as an inducer of apoptosis. Pajusto and coworkers [48 ] could demonstrate a proapoptotic effect of ROS on T cells, and Hansson et al. [49 ] demonstrate that monocytes are able to initiate apoptosis in autologous NK cells through a release of oxygen radicals. Furthermore, Warren et al. [50 ] observed that exposure of bovine EC to chemically generated ROS leads to programmed cell death in these cells. In a more detailed analysis, Madesh and colleagues [51 ] described that artificially generated ROS mediate apoptosis in rat EC via elevation of intracellular calcium concentration, leading to membrane depolarization of mitochondria and caspase activation. However, a clear cellular source of ROS as well as physiological stimuli, which are able to induce an appropriate ROS production in these cells leading to EC apoptosis, remained to be defined until now. Here, we could show for the first time that human monocytes activated by the platelet-derived chemokine PF4 induce a ROS-dependent programmed cell death in human EC. Interestingly, fMLP, as a potent inducer of rather short-lived ROS production in monocytes, failed to provoke EC cytotoxicity. This indicates that the duration of the stimulus-induced ROS release may play a critical role in the induction of the latter process. After activation with different soluble stimuli, monocytes produce oxygen radicals for a defined time period. Although the fMLP- and IL-8-induced responses are restricted to the first few minutes after stimulation, PF4-mediated oxidative burst occurs later in its onset and is remarkably longer in duration (lasting up to 60 min) [52 , 53 ]. In addition to this, we show here that as compared with monocytes attached to plastic surfaces, contact with EC results in a significantly sustained monocyte oxidative burst response in PF4-treated monocytes (Fig. 4) . Interestingly, irrespective of whether the monocytes were in contact to EC or plastic, ROS release induced by fMLP was not affected (data not shown). This suggests that only long-lasting, oxidative stress, as observed with PF4-activated monocytes attached to EC, is able to mediate killing of the latter cells.

Besides its capacity to induce oxygen radicals, PF4 also mediates the differentiation of monocytes into macrophages. However, this process appears not to be linked to monocyte cytotoxicity, as the development of macrophages induced by PF4 requires at least 48 h of stimulation ([54 ] and unpublished results), and a first cytotoxic effect became visible already after 12 h of culture (Fig. 2B) . Furthermore, GM-CSF, which is a potent elicitor of monocyte differentiation but did not induce any production of ROS in these cells (data not shown), failed to promote a cytotoxic effect against EC (Figs. 1 2 3) .

According to our data, direct cell–cell contact between monocytes and EC is an indispensable prerequisite for PF4-mediated cytotoxicity against EC (Fig. 3) . This is in line with findings by others, showing that leukocyte oxidative burst requires adhesion of these cells [55 ]. However, we could show that simply physical contact between EC and monocytes is not sufficient to induce the monocytic response. Moreover, our studies using inhibitory antibodies against adhesion molecules revealed that killing of EC by the monocytes strictly depends on the binding of monocyte β2-integrins and EC-expressed ICAM-1 (Fig. 3) . In all probability, β2-integrin binding to its counter-receptor provides a costimulatory signal in monocytes, leading to prolonged production of ROS. Indeed, we found that the presence of antibodies against CD18 and ICAM-1 drastically reduces PF4-induced ROS generation of monocytes attached to EC (Fig. 4A) . In an earlier study, we reported that PF4-mediated adherence of neutrophils to EC also involves β2-integrins and that these integrins provide a costimulatory signal leading to neutrophil exocytosis [56 ]. Furthermore, Elner et al. [57 ] described that the induction of apoptosis in human retinal pigment epithelial cells mediated by IFN-{gamma}-stimulated monocytes also depends on the interaction of these molecules, and in an early report, Jonjic et al. [58 ] showed the essential role of β2-integrins in the IFN-{gamma}/LPS-induced cytotoxic effect of monocytes on EC. It should be noted that the experimental settings in the latter study were different from those applied by us. Although Jonjic and coworkers [58 ] activated and differentiated the monocytes for 20 h with IFN-{gamma} and LPS before coculture with EC, we used fresh and undifferentiated blood monocytes. Moreover, although we observed a cytotoxic effect already after 15 h of coculture (Fig. 2) , EC killing was described by Jonjic and coworkers [58 ] to occur between 24 h and 48 h of culture, indicating that different cellular mechanisms of cytotoxicity may be involved in the two experimental systems.

Beside oxidative stress, other potential cytotoxic mechanisms of PF4-activated monocytes were explored. As described earlier, the time-course of PF4-induced cytotoxicity parallels that of TNF release [59 ]. However, as neither supernatants of PF4-activated monocytes (Fig. 3) nor stimulated monocytes/EC cocultures in a transwell system led to EC killing, a potential, direct cytotoxic effect by TNF or other soluble factors induced by PF4 in monocytes can be excluded. Furthermore, these findings also eliminate the potential participation of soluble monocyte proteases in PF4-mediated cytotoxicity of EC. This is in line with our observation that protease inhibitors of broad and different specificities were without effect on the killing process.

Cytotoxicity of stimulated monocytes can be targeted against different cell types, for example, tumor cells or epithelial cells [57 , 60 ]. In this work, we have shown that PF4-activated monocytes develop cytotoxicity against EC but not against cells of the lung epithelial cell line A549. Surprisingly, A549 cells express constitutively high amounts of ICAM-1 ([61 ] and our own observations), indicating that a lack of interaction with the corresponding β2-integrins cannot be the reason for their insensitivity to ROS attack. It is possible that survival of lung epithelial cells in their physiological environment requires a higher resistance to oxidative stress than that of blood vessel-derived EC.

So far, the in vivo physiological situation, where PF4-mediated cytotoxicity may play a role, is still speculative. Our observation, that the presence of serum drastically reduces EC killing, argues for strict, local restriction of this potentially harmful, biological effect to regions where serum components are absent. Such serum-free microenvironments may arise through platelet activation, leading to the formation of thrombi, which are normally firmly attached to the vessel wall. Thrombus formation would not only exclude serum-derived inhibitors but as a source for PF4, would also allow the formation of high, local concentrations of the chemokine required to induce monocyte cytotoxicity. As normal serum concentrations of PF4 may reach 0.9–1.9 µM [3 ], the amounts released in platelet aggregates can be assumed to be much higher. With regard to this, the relatively high threshold of ~0.125 µM PF4 for the induction of a cytotoxic effect could serve to prevent unintended activation of monocytes by low concentration of the chemokine released from decaying platelets. Together, these mechanisms would strictly localize cytotoxicity and prevent extensive damage of the endothelium. On the other hand, such selective activation of cytotoxic monocytes in close proximity to thrombi could serve to effectively eliminate damaged EC, and removal of intact EC would facilitate the passage of inflammatory leukocytes and mediators, accelerating the formation of an inflammatory focus.

Oxidative stress has been identified as a central, pathogenic factor of many diseases, such as arteriosclerosis, heart attacks, ischemia/reperfusion injury, or chronic inflammatory diseases (reviewed in refs. [62 , 63 ]). Strikingly, practically all of these disorders are accompanied by an acute or chronic activation of thrombocytes. Furthermore, it was shown that in cystathioninsynthase-deficient mice, which display enhanced thrombus formation, injuries of the endothelium are accompanied by enhanced oxidative stress [64 ].

In summary, our data provide evidence that the long-lasting release of ROS by PF4-activated monocytes induces apoptosis selectively in EC. This cytotoxic effect requires direct cell contact between effector and target cells, which is mediated by β2-integrins as well as their corresponding counter ligand. A future goal will be to understand if and how ROS formation induced by mediators of activated platelets is involved in pathological processes. In further studies, we will investigate the role of platelet-induced ROS production in vivo in animal models of atherosclerosis and antibody-induced autoimmune diseases.


arrow
ACKNOWLEDGEMENTS
 
This work was supported in part by Deutsche Forschungsgemeinschaft, Project PE 967/1-1, and Sonderforschungsbereich 415, Project B6. We thank Mrs. Alette Hettfleisch and Mrs. Diana Heinrich (Division of Biochemical Immunology, Research Center Borstel, Germany) for perfect technical assistance. We greatly acknowledge Mrs. Erika Kaltenhäuser (Division of Immune Cell Analytics, Research Center Borstel) for the preparation of monocytes. We thank Dr. Holger Heine (Division of Innate Immunity, Research Center Borstel) for analyzing PF4 effects on TLR4-transfected HEK293 cells.

Received September 3, 2007; revised December 14, 2007; accepted December 17, 2007.


arrow
REFERENCES
 
    1
  1. Brandt, E., Petersen, F., Ludwig, A., Ehlert, J. E., Bock, L., Flad, H. D. (2000) The β-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation J. Leukoc. Biol. 67,471-478[Abstract]
  2. 2
  3. Kameyoshi, Y., Dorschner, A., Mallet, A. I., Christophers, E., Schroder, J. M. (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils J. Exp. Med. 176,587-592[Abstract/Free Full Text]
  4. 3
  5. Files, J. C., Malpass, T. W., Yee, E. K., Ritchie, J. L., Harker, L. A. (1981) Studies of human platelet {alpha}-release in vivo Blood 58,607-618[Free Full Text]
  6. 4
  7. Walz, A., Dewald, B., von Tscharner, V., Baggiolini, M. (1989) Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils J. Exp. Med. 170,1745-1750[Abstract/Free Full Text]
  8. 5
  9. Baggiolini, M., Dewald, B., Moser, B. (1994) Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines Adv. Immunol. 55,97-179[Medline]
  10. 6
  11. Rollins, B. J. (1997) Chemokines Blood 90,909-928[Free Full Text]
  12. 7
  13. Zlotnik, A., Morales, J., Hedrick, J. A. (1999) Recent advances in chemokines and chemokine receptors Crit. Rev. Immunol. 19,1-47[Medline]
  14. 8
  15. Petersen, F., Ludwig, A., Flad, H. D., Brandt, E. (1996) TNF-{alpha} renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines J. Immunol. 156,1954-1962[Abstract]
  16. 9
  17. Fleischer, J., Grage-Griebenow, E., Kasper, B., Heine, H., Ernst, M., Brandt, E., Flad, H. D., Petersen, F. (2002) Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells J. Immunol. 169,770-777[Abstract/Free Full Text]
  18. 10
  19. Pervushina, O., Scheuerer, B., Reiling, N., Behnke, L., Schroder, J. M., Kasper, B., Brandt, E., Bulfone-Paus, S., Petersen, F. (2004) Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients J. Immunol. 173,2060-2067[Abstract/Free Full Text]
  20. 11
  21. Brindley, L. L., Sweet, J. M., Goetzl, E. J. (1983) Stimulation of histamine release from human basophils by human platelet factor 4 J. Clin. Invest. 72,1218-1223[Medline]
  22. 12
  23. Hayashi, N., Chihara, J., Kobayashi, Y., Kakazu, T., Kurachi, D., Yamamoto, T., Nakajima, S. (1994) Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion Int. Arch. Allergy Immunol. 104(Suppl. 1),57-59[CrossRef][Medline]
  24. 13
  25. Marti, F., Bertran, E., Llucia, M., Villen, E., Peiro, M., Garcia, J., Rueda, F. (2002) Platelet factor 4 induces human natural killer cells to synthesize and release interleukin-8 J. Leukoc. Biol. 72,590-597[Abstract/Free Full Text]
  26. 14
  27. Petersen, F., Bock, L., Flad, H. D., Brandt, E. (1999) Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8 Blood 94,4020-4028[Abstract/Free Full Text]
  28. 15
  29. Petersen, F., Ludwig, A., Flad, H. D., Brandt, E. (1996) TNF-{alpha} renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines J. Immunol. 156,1954-1962[Abstract]
  30. 16
  31. Han, Z. C., Lu, M., Li, J., Defard, M., Boval, B., Schlegel, N., Caen, J. P. (1997) Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents Blood 89,2328-2335[Abstract/Free Full Text]
  32. 17
  33. Fleischer, J., Grage-Griebenow, E., Kasper, B., Heine, H., Ernst, M., Brandt, E., Flad, H. D., Petersen, F. (2002) Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells J. Immunol. 169,770-777[Abstract/Free Full Text]
  34. 18
  35. Liu, C. Y., Battaglia, M., Lee, S. H., Sun, Q. H., Aster, R. H., Visentin, G. P. (2005) Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25– (nonregulatory) T cells J. Immunol. 174,2680-2686[Abstract/Free Full Text]
  36. 19
  37. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., Sharpe, R. J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides Science 247,77-79[Abstract/Free Full Text]
  38. 20
  39. Watson, J. B., Getzler, S. B., Mosher, D. F. (1994) Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor J. Clin. Invest. 94,261-268[Medline]
  40. 21
  41. Gengrinovitch, S., Greenberg, S. M., Cohen, T., Gitay-Goren, H., Rockwell, P., Maione, T. E., Levi, B. Z., Neufeld, G. (1995) Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms J. Biol. Chem. 270,15059-15065[Abstract/Free Full Text]
  42. 22
  43. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., Sharpe, R. J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides Science 247,77-79[Abstract/Free Full Text]
  44. 23
  45. Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., Romagnani, S., Serio, M., Romagnani, P. (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 J. Exp. Med. 197,1537-1549[Abstract/Free Full Text]
  46. 24
  47. Gupta, S. K., Singh, J. P. (1994) Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression J. Cell Biol. 127,1121-1127[Abstract/Free Full Text]
  48. 25
  49. Pervushina, O., Scheuerer, B., Reiling, N., Behnke, L., Schroder, J. M., Kasper, B., Brandt, E., Bulfone-Paus, S., Petersen, F. (2004) Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients J. Immunol. 173,2060-2067[Abstract/Free Full Text]
  50. 26
  51. Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H. D., Petersen, F. (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages Blood 95,1158-1166[Abstract/Free Full Text]
  52. 27
  53. Pervushina, O., Scheuerer, B., Reiling, N., Behnke, L., Schroder, J. M., Kasper, B., Brandt, E., Bulfone-Paus, S., Petersen, F. (2004) Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients J. Immunol. 173,2060-2067[Abstract/Free Full Text]
  54. 28
  55. Babior, B. M. (2000) Phagocytes and oxidative stress Am. J. Med. 109,33-44[CrossRef][Medline]
  56. 29
  57. Brandt, E., Van Damme, J., Flad, H. D. (1991) Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III Cytokine 3,311-321[CrossRef][Medline]
  58. 30
  59. Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H. D., Petersen, F. (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages Blood 95,1158-1166[Abstract/Free Full Text]
  60. 31
  61. Petersen, F., Ludwig, A., Flad, H. D., Brandt, E. (1996) TNF-{alpha} renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines J. Immunol. 156,1954-1962[Abstract]
  62. 32
  63. Brandt, E., Van Damme, J., Flad, H. D. (1991) Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III Cytokine 3,311-321[CrossRef][Medline]
  64. 33
  65. Jaffe, E. A., Nachman, R. L., Becker, C. G., Minick, C. R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J. Clin. Invest. 52,2745-2756[Medline]
  66. 34
  67. Schönbeck, U., Brandt, E., Petersen, F., Flad, H. D., Loppnow, H. (1995) IL-8 specifically binds to endothelial but not to smooth muscle cells J. Immunol. 154,2375-2383[Abstract]
  68. 35
  69. Grage-Griebenow, E., Lorenzen, D., Fetting, R., Flad, H. D., Ernst, M. (1993) Phenotypical and functional characterization of Fc {gamma} receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity Eur. J. Immunol. 23,3126-3135[Medline]
  70. 36
  71. Ahmed, S. A., Gogal, R. M., Jr, Walsh, J. E. (1994) A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay J. Immunol. Methods 170,211-224[CrossRef][Medline]
  72. 37
  73. Pervushina, O., Scheuerer, B., Reiling, N., Behnke, L., Schroder, J. M., Kasper, B., Brandt, E., Bulfone-Paus, S., Petersen, F. (2004) Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients J. Immunol. 173,2060-2067[Abstract/Free Full Text]
  74. 38
  75. Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H. D., Petersen, F. (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages Blood 95,1158-1166[Abstract/Free Full Text]
  76. 39
  77. Pervushina, O., Scheuerer, B., Reiling, N., Behnke, L., Schroder, J. M., Kasper, B., Brandt, E., Bulfone-Paus, S., Petersen, F. (2004) Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients J. Immunol. 173,2060-2067[Abstract/Free Full Text]
  78. 40
  79. Freund, M., Kleine, H. D. (1992) The role of GM-CSF in infection Infection 20(Suppl. 2),S84-S92[CrossRef][Medline]
  80. 41
  81. Jones, T. C. (1996) The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease Med. Oncol. 13,141-147[Medline]
  82. 42
  83. Mantovani, A., Dejana, E. (1989) Cytokines as communication signals between leukocytes and endothelial cells Immunol. Today 10,370-375[CrossRef][Medline]
  84. 43
  85. Petersen, F., Bock, L., Flad, H. D., Brandt, E. (1999) Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8 Blood 94,4020-4028[Abstract/Free Full Text]
  86. 44
  87. Schenk, B. I., Petersen, F., Flad, H. D., Brandt, E. (2002) Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration J. Immunol. 169,2602-2610[Abstract/Free Full Text]
  88. 45
  89. Balcerczyk, A., Soszynski, M., Rybaczek, D., Przygodzki, T., Karowicz-Bilinska, A., Maszewski, J., Bartosz, G. (2005) Induction of apoptosis and modulation of production of reactive oxygen species in human endothelial cells by diphenyleneiodonium Biochem. Pharmacol. 69,1263-1273[CrossRef][Medline]
  90. 46
  91. Madesh, M., Hawkins, B. J., Milovanova, T., Bhanumathy, C. D., Joseph, S. K., Ramachandrarao, S. P., Sharma, K., Kurosaki, T., Fisher, A. B. (2005) Selective role for superoxide in InsP3 receptor-mediated mitochondrial dysfunction and endothelial apoptosis J. Cell Biol. 170,1079-1090[Abstract/Free Full Text]
  92. 47
  93. Babior, B. M. (2000) Phagocytes and oxidative stress Am. J. Med. 109,33-44[CrossRef][Medline]
  94. 48
  95. Pajusto, M., Toivonen, T. H., Tarkkanen, J., Jokitalo, E., Mattila, P. S. (2005) Reactive oxygen species induce signals that lead to apoptotic DNA degradation in primary CD4+ T cells Apoptosis 10,1433-1443[CrossRef][Medline]
  96. 49
  97. Hansson, M., Asea, A., Ersson, U., Hermodsson, S., Hellstrand, K. (1996) Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites J. Immunol. 156,42-47[Abstract]
  98. 50
  99. Warren, M. C., Bump, E. A., Medeiros, D., Braunhut, S. J. (2000) Oxidative stress-induced apoptosis of endothelial cells Free Radic. Biol. Med. 29,537-547[CrossRef][Medline]
  100. 51
  101. Madesh, M., Hawkins, B. J., Milovanova, T., Bhanumathy, C. D., Joseph, S. K., Ramachandrarao, S. P., Sharma, K., Kurosaki, T., Fisher, A. B. (2005) Selective role for superoxide in InsP3 receptor-mediated mitochondrial dysfunction and endothelial apoptosis J. Cell Biol. 170,1079-1090[Abstract/Free Full Text]
  102. 52
  103. Walz, A., Meloni, F., Clark-Lewis, I., von Tscharner, V., Baggiolini, M. (1991) [Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA J. Leukoc. Biol. 50,279-286[Abstract]
  104. 53
  105. Pervushina, O., Scheuerer, B., Reiling, N., Behnke, L., Schroder, J. M., Kasper, B., Brandt, E., Bulfone-Paus, S., Petersen, F. (2004) Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients J. Immunol. 173,2060-2067[Abstract/Free Full Text]
  106. 54
  107. Scheuerer, B., Ernst, M., Dürrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H-D., Petersen, F. (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages Blood 95,1158-1166[Abstract/Free Full Text]
  108. 55
  109. Nathan, C. F. (1987) Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes J. Clin. Invest. 80,1550-1560[Medline]
  110. 56
  111. Petersen, F., Bock, L., Flad, H. D., Brandt, E. (1999) Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8 Blood 94,4020-4028[Abstract/Free Full Text]
  112. 57
  113. Elner, S. G., Yoshida, A., Bian, Z. M., Kindezelskii, A. L., Petty, H. R., Elner, V. M. (2003) Human RPE cell apoptosis induced by activated monocytes is mediated by caspase-3 activation Trans. Am. Ophthalmol. Soc. 101,77-89[Medline]
  114. 58
  115. Jonjic, N., Jilek, P., Bernasconi, S., Peri, G., Martin-Padura, I., Cenzuales, S., Dejana, E., Mantovani, A. (1992) Molecules involved in the adhesion and cytotoxicity of activated monocytes on endothelial cells J. Immunol. 148,2080-2083[Abstract]
  116. 59
  117. Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H. D., Petersen, F. (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages Blood 95,1158-1166[Abstract/Free Full Text]
  118. 60
  119. Martin, J. H., Edwards, S. W. (1993) Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing J. Immunol. 150,3478-3486[Abstract]
  120. 61
  121. Arnold, R., Konig, W. (1996) ICAM-1 expression and low-molecular-weight G-protein activation of human bronchial epithelial cells (A549) infected with RSV J. Leukoc. Biol. 60,766-771[Abstract]
  122. 62
  123. Davies, K. J. (1995) Oxidative stress: the paradox of aerobic life Biochem. Soc. Symp. 61,1-31[Medline]
  124. 63
  125. Cai, H., Harrison, D. G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress Circ. Res. 87,840-844[Abstract/Free Full Text]
  126. 64
  127. Eberhardt, R. T., Forgione, M. A., Cap, A., Leopold, J. A., Rudd, M. A., Trolliet, M., Heydrick, S., Stark, R., Klings, E. S., Moldovan, N. I., Yaghoubi, M., Goldschmidt-Clermont, P. J., Farber, H. W., Cohen, R., Loscalzo, J. (2000) Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia J. Clin. Invest. 106,483-491[Medline]



This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
P. Au, J. Tam, D. G. Duda, P.-C. Lin, L. L. Munn, D. Fukumura, and R. K. Jain
Paradoxical Effects of PDGF-BB Overexpression in Endothelial Cells on Engineered Blood Vessels In Vivo
Am. J. Pathol., July 1, 2009; 175(1): 294 - 302.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.0907592v1
83/4/936    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woller, G.
Right arrow Articles by Petersen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woller, G.
Right arrow Articles by Petersen, F.